FDA approves first drug to slow Alzheimer’s in controversial decision
By
Alicia Lasek
Jun 07, 2021
The evidence convincingly shows that aducanumab (Aduhelm) removes beta amyloid — a hallmark of Alzheimer’s — from the brain, slowing the disease’s progression and giving patients and families much-needed...
CMS must allow nursing homes to treat neuropsychiatric symptoms of Alzheimer’s
By
Sue Peschin
Chad Worz
Jan 09, 2024
As we start 2024 anew and recover from family-filled holidays, we may have been reminded that celebrations often serve double duty as an informal assessment of health and well-being — including neuropsychiatric...